Recent patents in allergy and immunology: The interleukin‐2 receptor pathway agonist rezpegaldesleukin (REZPEG) for the rescue of regulatory T cells in chronic inflammatory and autoimmune diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent patents in allergy and immunology: The interleukin‐2 receptor pathway agonist rezpegaldesleukin (REZPEG) for the rescue of regulatory T cells in chronic inflammatory and autoimmune diseases

Published:2024-08-16 Issue:9 Volume:79 Page:2565-2566
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Fanton Christie¹,Zalevsky Jonathan¹

Affiliation:

1. Nektar Therapeutics San Francisco California USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.16271

Reference8 articles.

1. Regulatory T Cells and Human Disease

2. The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis

3. Selective expansion of regulatory T cells by NKTR-358 in healthy volunteers and patients with systemic lupus erythematosus

4. Revisiting IL-2: Biology and therapeutic prospects

5. AshrafzadehA DoddSW JacksonKA et al.Dosing regimens for selective Treg stimulator RUR20kD‐IL‐2 and related compositions. WO2023/114833. PCT/US2022/081541.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP